Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension.

Wirta, David; Malhotra, Ranjan; Peace, James; Shen Lee, Bridgitte; Mitchell, Brittany; Sall, Kenneth; McMenemy, Matthew

Wirta, David; Malhotra, Ranjan; Peace, James; Shen Lee, Bridgitte; Mitchell, Brittany; Sall, Kenneth; McMenemy, Matthew.

Affiliation

Wirta D; Eye Research Foundation (D.W.), Newport Beach, CA; Ophthalmology Associates (R.M.), St. Louis, MO; Peace Eyecare (J.P.), Inglewood, CA; Vision Optique (B.S.L.), Houston, TX; Sun Pharmaceutical Industries, Inc., (B.M.) Princeton, NJ; Sall Research Medical Center, Inc., (K.S.) Artesia, CA; and Lone Star Eye Care, P.A (M.M.), Sugar Land, TX.

Eye Contact Lens ; 48(4): 149-154, 2022 Apr 01.

Article in En | MEDLINE | ID: mdl-35296626

Subject(s)

Glaucoma, Open-Angle; Ocular Hypertension; Prostaglandins F, Synthetic; Antihypertensive Agents/adverse effects; Benzalkonium Compounds/adverse effects; Glaucoma, Open-Angle/drug therapy; Humans; Latanoprost/therapeutic use; Ocular Hypertension/chemically induced; Ocular Hypertension/drug therapy; Ophthalmic Solutions; Prostaglandins F, Synthetic/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostaglandins F, Synthetic / Glaucoma, Open-Angle / Ocular Hypertension Type of study: Clinical_trials Limits: Humans Language: En Journal: Eye Contact Lens Journal subject: OFTALMOLOGIA Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google